StemoniX is accelerating the discovery of new drugs by creating ready-to-use pre-clinical plates of biologically relevant human micro-organs. They currently are launching their microHeart and microBrain products and services to help find cures for cardiac and nervous system diseases as well as pandemics.
Ping was diagnosed with Hodgkins Lymphoma in 2012 and became a survivor after being told he was resistant to chemo. After receiving the max potency (max toxicity) treatment to cure his cancer, the only way to test if his heart survived the toxicity was a post-measurement. Stunned that there wasn’t a better way to pre-test, Ping took his knowledge of nanotechnology and knack of leading cross-functional teams to solve challenging problems to the life science industry. One of less than five people in the world with his mix of expertise, Ping has now formed and led a team that has, in less than a year, become a qualified supplier to one of the largest pharmaceutical companies in the world.
2016 MN Cup
Johnson & Johnson’s JLabs